Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BRYN.DE Stock Summary
Top 10 Correlated ETFs
BRYN.DE
In the News
BRYN.DE Financial details
Company Rating
Strong Buy
Market Cap
808.41B
Income
96.22B
Revenue
439.34B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
396.5K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
10.36
Forward P/E
-
PEG
-0.28
P/S
2
P/B
1.51
P/C
-
P/FCF
29.99
Quick Ratio
83.19
Current Ratio
83.19
Debt / Equity
0.23
LT Debt / Equity
0.22
-
-
EPS (TTM)
26.89
EPS next Y
-
EPS next Q
-
EPS this Y
-542.26%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
5.91%
Revenue last 5Y
6.07%
Revenue Q/Q
105.24%
EPS Q/Q
-
-
-
-
-
SMA20
-0.19%
SMA50
12.46%
SMA100
15.77%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
15%
ROC
-0.04%
Gross Margin
100%
Oper. Margin
-9%
Profit Margin
19%
Payout
-
Shs Outstand
2.17B
Shs Float
2.16B
-
-
-
-
Target Price
-
52W Range
273.25-407.4
52W High
-7.52%
52W Low
+37.88%
RSI
60.59
Rel Volume
0.56
Avg Volume
9.45K
Volume
5.25K
Perf Week
2.39%
Perf Month
3.52%
Perf Quarter
10.38%
Perf Half Y
8.54%
-
-
-
-
Beta
0.894
-
-
Volatility
2.6%, 5.05%
Prev Close
0.43%
Price
376.4
Change
1.07%
BRYN.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 133.51 | 119.69 | 156.55 | 106.29 | 202.15 | |
Net income per share | 33.22 | 17.78 | 39.7 | -10.01 | 44.27 | |
Operating cash flow per share | 15.78 | 16.63 | 17.4 | 16.89 | 22.64 | |
Free cash flow per share | 9.27 | 11.19 | 11.54 | 9.88 | 13.71 | |
Cash per share | 52.22 | 57.82 | 64.77 | 58.36 | 77.14 | |
Book value per share | 173.32 | 185.29 | 223.46 | 214.39 | 258.26 | |
Tangible book value per share | 128.54 | 145.05 | 182.13 | 169.43 | 210.19 | |
Share holders equity per share | 173.32 | 185.29 | 223.46 | 214.39 | 258.26 | |
Interest debt per share | 43.79 | 50.58 | 52.28 | 57.68 | 61.32 | |
Market cap | 554.88B | 551.17B | 681.76B | 678.38B | 776.2B | |
Enterprise value | 594.08B | 620.08B | 707.84B | 765.31B | 866.45B | |
P/E ratio | 6.82 | 12.96 | 7.58 | -30.75 | 8.07 | |
Price to sales ratio | 1.7 | 1.93 | 1.92 | 2.9 | 1.77 | |
POCF ratio | 14.34 | 13.86 | 17.29 | 18.22 | 15.78 | |
PFCF ratio | 24.44 | 20.6 | 26.08 | 31.18 | 26.06 | |
P/B Ratio | 1.31 | 1.24 | 1.35 | 1.44 | 1.38 | |
PTB ratio | 1.31 | 1.24 | 1.35 | 1.44 | 1.38 | |
EV to sales | 1.82 | 2.17 | 2 | 3.27 | 1.97 | |
Enterprise value over EBITDA | -8.84 | -6.02 | -9.87 | -47.58 | -6.72 | |
EV to operating cash flow | 15.36 | 15.59 | 17.96 | 20.56 | 17.61 | |
EV to free cash flow | 26.16 | 23.17 | 27.07 | 35.17 | 29.09 | |
Earnings yield | 0.15 | 0.08 | 0.13 | -0.03 | 0.12 | |
Free cash flow yield | 0.04 | 0.05 | 0.04 | 0.03 | 0.04 | |
Debt to equity | 0.24 | 0.26 | 0.23 | 0.26 | 0.23 | |
Debt to assets | 0.13 | 0.13 | 0.12 | 0.13 | 0.12 | |
Net debt to EBITDA | -0.58 | -0.67 | -0.36 | -5.4 | -0.7 | |
Current ratio | 34.96 | 52.01 | 79.24 | 72.82 | 39.71 | |
Interest coverage | -19.5 | -27.82 | -19.76 | -6.2 | -28.25 | |
Income quality | 0.47 | 0.92 | 0.43 | -1.69 | 0.51 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.14 | 0.12 | 0.11 | 0.11 | 0.11 | |
Capex to operating cash flow | -0.41 | -0.33 | -0.34 | -0.42 | -0.39 | |
Capex to revenue | -0.05 | -0.05 | -0.04 | -0.07 | -0.04 | |
Capex to depreciation | -1.59 | -1.23 | -1.24 | -1.42 | -1.55 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 359.92 | 272.25 | 446.79 | 219.75 | 507.22 | |
ROIC | -0.12 | -0.16 | -0.11 | -0.03 | -0.17 | |
Return on tangible assets | 0.12 | 0.06 | 0.11 | -0.03 | 0.1 | |
Graham Net | -91.54 | -103.53 | -113.45 | -131.77 | -137.31 | |
Working capital | 159.15B | 170.79B | 183.93B | 174.46B | 206.51B | |
Tangible asset value | 315.04B | 346.92B | 412.57B | 373.31B | 456.82B | |
Net current asset value | -225.33B | -248.25B | -257.57B | -290.95B | -287.37B | |
Invested capital | 0.24 | 0.26 | 0.23 | 0.26 | 0.23 | |
Average receivables | 35.53B | 35.84B | 37.71B | 43.93B | 46.25B | |
Average payables | 18.18B | 38.17B | 40.34B | 42.67B | 22.32B | |
Average inventory | 9.93B | 19.53B | 20.08B | 23.16B | 12.68B | |
Days sales outstanding | 39.97 | 45.71 | 40.72 | 75.28 | 36.72 | |
Days payables outstanding | 89.05 | 83.01 | 92.15 | 49.34 | 0 | |
Days of inventory on hand | 48.62 | 39.88 | 47.44 | 28.04 | 0 | |
Receivables turnover | 9.13 | 7.98 | 8.96 | 4.85 | 9.94 | |
Payables turnover | 4.1 | 4.4 | 3.96 | 7.4 | 0 | |
Inventory turnover | 7.51 | 9.15 | 7.69 | 13.02 | 0 | |
ROE | 0.19 | 0.1 | 0.18 | -0.05 | 0.17 | |
Capex per share | -6.52 | -5.44 | -5.86 | -7.02 | -8.93 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 42.1 | 55 | 57.75 | 29.23 | 0 | |
Net income per share | 8.25 | 16.25 | 16.52 | -5.88 | 0 | |
Operating cash flow per share | 4.64 | 3.98 | 5.72 | 6.3 | 0 | |
Free cash flow per share | 2.56 | 2.28 | 3.56 | 3.85 | 0 | |
Cash per share | 58.44 | 59.79 | 67.78 | 72.45 | 0 | |
Book value per share | 214.67 | 230.95 | 248.3 | 242.04 | 0 | |
Tangible book value per share | 169.65 | 184.36 | 200.56 | 193.32 | 0 | |
Share holders equity per share | 214.67 | 230.95 | 248.3 | 242.04 | 0 | |
Interest debt per share | 56.3 | 57.14 | 58.22 | 58.07 | 0 | |
Market cap | 677.49B | 678.12B | 741.34B | 763.34B | 0 | |
Enterprise value | 764.42B | 775B | 816.63B | 857.28B | 90.25B | |
P/E ratio | 9.32 | 4.77 | 5.16 | -14.95 | 0 | |
Price to sales ratio | 7.31 | 5.64 | 5.9 | 12.03 | 0 | |
POCF ratio | 66.41 | 78.01 | 59.62 | 55.84 | 0 | |
PFCF ratio | 120.04 | 136.17 | 95.67 | 91.24 | 0 | |
P/B Ratio | 1.43 | 1.34 | 1.37 | 1.45 | 0 | |
PTB ratio | 1.43 | 1.34 | 1.37 | 1.45 | 0 | |
EV to sales | 8.25 | 6.45 | 6.5 | 13.51 | 0.69 | |
Enterprise value over EBITDA | 29.46 | 15.89 | -44.47 | -10.67 | -5.53 | |
EV to operating cash flow | 74.94 | 89.15 | 65.68 | 62.72 | 6.27 | |
EV to free cash flow | 135.44 | 155.62 | 105.38 | 102.47 | 10.38 | |
Earnings yield | 0.03 | 0.05 | 0.05 | -0.02 | 0 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Debt to equity | 0.26 | 0.25 | 0.23 | 0.24 | 0.23 | |
Debt to assets | 0.13 | 0.12 | 0.12 | 0.12 | 0.12 | |
Net debt to EBITDA | 3.35 | 1.99 | -4.1 | -1.17 | -5.53 | |
Current ratio | 72.82 | 62.64 | 64.92 | 83.19 | 39.71 | |
Interest coverage | 20.36 | 37.53 | -17.18 | -66.33 | -15.25 | |
Income quality | 0.56 | 0.24 | 0.34 | -1.09 | 0.38 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | |
Capex to operating cash flow | -0.45 | -0.43 | -0.38 | -0.39 | -0.4 | |
Capex to revenue | -0.05 | -0.03 | -0.04 | -0.08 | -0.04 | |
Capex to depreciation | -1.65 | -1.22 | -1.51 | -1.65 | -1.82 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 199.68 | 290.6 | 303.77 | 178.98 | 0 | |
ROIC | 0.03 | 0.06 | -0.03 | -0.1 | -0.02 | |
Return on tangible assets | 0.02 | 0.04 | 0.04 | -0.01 | 0.04 | |
Graham Net | -131.95 | -136.44 | -133.86 | -132.89 | 0 | |
Working capital | 174.46B | 180.18B | 195.97B | 207.44B | 206.51B | |
Tangible asset value | 373.31B | 402.76B | 436.09B | 419.58B | 456.82B | |
Net current asset value | -290.95B | -297.71B | -290.78B | -275.24B | -287.37B | |
Invested capital | 0.26 | 0.25 | 0.23 | 0.24 | 0.23 | |
Average receivables | 46.83B | 50.39B | 52.07B | 52.19B | 48.46B | |
Average payables | 46.3B | 48.44B | 52.08B | 25.96B | 0 | |
Average inventory | 25.23B | 25.43B | 25.4B | 12.65B | 0 | |
Days sales outstanding | 46.93 | 39.32 | 37.03 | 74.81 | 30.56 | |
Days payables outstanding | 72.21 | 117.21 | 100.87 | 0 | 0 | |
Days of inventory on hand | 41.04 | 57.21 | 49.14 | 0 | 0 | |
Receivables turnover | 1.92 | 2.29 | 2.43 | 1.2 | 2.95 | |
Payables turnover | 1.25 | 0.77 | 0.89 | 0 | 0 | |
Inventory turnover | 2.19 | 1.57 | 1.83 | 0 | 0 | |
ROE | 0.04 | 0.07 | 0.07 | -0.02 | 0.07 | |
Capex per share | -2.07 | -1.7 | -2.15 | -2.44 | 0 |
BRYN.DE Frequently Asked Questions
What is Berkshire Hathaway Inc. stock symbol ?
Berkshire Hathaway Inc. is a US stock , located in Omaha of Ne and trading under the symbol BRYN.DE
What is Berkshire Hathaway Inc. stock quote today ?
Berkshire Hathaway Inc. stock price is $376.4 today.
Is Berkshire Hathaway Inc. stock public?
Yes, Berkshire Hathaway Inc. is a publicly traded company.